Skip to main content
. Author manuscript; available in PMC: 2024 Nov 1.
Published in final edited form as: Neuropharmacology. 2023 Jul 16;238:109666. doi: 10.1016/j.neuropharm.2023.109666

Figure 3.

Figure 3.

(A) Effect of ADX106772 on oxycodone self-administration (Bonferroni: ****p ≤ 0.0001, active lever responses vs. 0 mg/kg active lever responses). (B) Time course of effects of ADX106772 on oxycodone self-administration (Dunnett’s: *p ≤ 0.05, vs. 0 mg/kg).